Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 1/2 1

Status

Withdrawn 1Recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2

Conditions

Glioblastoma 40Glioma 17Brain Neoplasms 14Astrocytoma 11Neuroblastoma 10Gliosarcoma 10Neoplasms 8Sarcoma, Ewing 7Rhabdomyosarcoma 6Recurrence 5Oligodendroglioma 5Sarcoma 4Medulloblastoma 4Neoplasm Metastasis 3Diffuse Intrinsic Pontine Glioma 3Wilms Tumor 2Small Cell Lung Carcinoma 2Pancreatic Neoplasms 2Osteosarcoma 2Melanoma 2Lymphoma, Follicular 2Hepatoblastoma 2Central Nervous System Neoplasms 2Spinal Cord Neoplasms 1Somatostatinoma 1Rhabdoid Tumor 1Refractory Solid Tumors 1Pyloric Stenosis, Hypertrophic 1Prostatic Neoplasms 1Pheochromocytoma 1

Interventions

Magnetic Resonance Spectroscopy 6Biopsy 6X-Rays 5Specimen Handling 5Phantoms, Imaging 5Nuclear Medicine Department, Hospital 4Cisplatin 3Carboplatin 3tazemetostat 2selpercatinib 2larotrectinib 2erdafitinib 2entrectinib 2ensartinib 2cabozantinib 2Topotecan 2Temozolomide 2Surveys and Questionnaires 2Radiation 2LY3023414 2Gemcitabine 2Etoposide 2Cyclophosphamide 2ulixertinib 1tipifarnib 1pegfilgrastim 1palbociclib 1olaparib 1niraparib 1mirdametinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Central Nervous System Neoplasms × Temozolomide × 90 days × Clear all
NCT07243470 2026-05-27

TARLATEM

Centre Leon Berard

Phase 1/2 Recruiting
70 enrolled
CNS

Glioma, Central Nervous System Neoplasms

NCT03554707 2026-05-08

SGT-53 in Children With Recurrent or Progressive CNS Malignancies

SynerGene Therapeutics, Inc.

Phase EARLY_PHASE1 Withdrawn
CNS

Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡